Awards
Paul Ehrlich Lectureship Award: Steven Ackerman, PhDThe Paul Ehrlich Lectureship Award is the most prestigious recognition given by the International Eosinophil Society. It honors an individual who has made exceptional, prolific, and high-quality research contributions that have significantly advanced our understanding of the molecular mechanisms of eosinophils in both health and disease. Dr. Ackerman will give the prestigious Paul Ehrlich Lecture on Tuesday, 8 July 2025 at 3:00 pm.
|
Lifetime Achievement AwardsThe IES Lifetime Achievement Award is a distinguished honor that celebrates exceptional contributions to eosinophil research and a lifelong commitment to advancing the understanding and treatment of eosinophil-associated diseases. The groundbreaking work of the awardees has profoundly influenced the field and inspired researchers and clinicians globally. |
2025 Lifetime Achievement Award: Hans-Uwe Simon, MD, PhD & Dagmar Simon, MDThe 2025 Lifetime Achievement Award will be given to both Hans-Uwe Simon and Dagmar Simon during the Congress. They will deliver the prestigious Lifetime Achievement Award Lecture on Wednesday, 9 July 2025 at 5:00 pm and accept their awards during the Awards Dinner on Thursday, 10 July 2025. |
|
|
|
|
2024 Lifetime Achievement Award: Gerald J. Gleich, MDThe 2024 Lifetime Achievement was awarded to Gerald J. Gleich during a special IES Webinar honoring his life and work in October of 2024. He will receive his award and special recognition during the Awards Dinner on Thursday, 10 July 2025.
Dr. Gleich has served on many committees and editorial boards, including Chair of the WHO Subcommittee on Standardization of Allergens, the editorial board of the Journal of Allergy and Clinical Immunology, the editorial Board of the Journal of Immunology, Member and Chair of the Board of Scientific Counselors, NIAID, Member and Chair of the Immunological Sciences Study Section NIH and Chair of the Data and Safety Monitoring Board of the NIAID. Dr. Gleich has received numerous awards and honors, including memberships in Phi Beta Kappa, Phi Kappa Phi, Alpha Omega Alpha and Sigma Xi, the American College of Physicians (Fellow), the American Society for Clinical Investigation, the American Association of Immunologists, the Collegium Internationale Allergologicum, the Association of American Physicians; named lectureships including the John M. Sheldon Memorial Lecturer of the American Academy of Allergy, Asthma and Immunology 1976, 1982 and 1988, the Stoll-Stunkard Lecturer American Society of Parasitologists, Distinguished Lecturer in Medical Sciences Mayo Clinic and Foundation; and awards including the Landmark in Allergy Award Recipient, Fellowship award of the American Association for the Advancement of Science, Honorable Membership in the Pharmacia Allergy Research Foundation, Mayo Clinic Distinguished Alumni Award, Scientific Achievement Award of Life Sciences Pennsylvania and Original Member, Highly Cited Researchers database, ISI Thomson Scientific. Lastly, Dr. Gleich has contributed over 700 articles to the scientific literature. He has seven children and eight grandchildren. He enjoys skiing and hiking. |
Eosinophilic Disease Translational Research Award: Seema Aceves, MD, PhDThe Eosinophilic Disease Translational Research Award recognizes a scientist whose translational research has helped lead to substantial improvement in the understanding, diagnosis and care of patients afflicted by eosinophilic disease. Patient-oriented translational research is a critical component towards improving outcomes in the era of personalized medicine, both for individual patients and for the community-at-large. Dr. Aceves will give a special lecture on Thursday, 10 July 2025 at 2:30 pm and accept her award during the Awards Dinner.
|
Dr. Steven Ackerman, who did his postdoctoral training with Jerry Gleich at the Mayo Clinic from 1979-1984, has nearly 45 years' experience studying the roles of innate immune cells, mainly eosinophils, in host immune responses and pathogenesis of parasitic, allergic and gastrointestinal diseases, focused on asthma and eosinophilic esophagitis (EoE). He has a world-class reputation performing seminal basic studies defining eosinophil protein biochemistry, structural biology, cellular and molecular biology, including mechanisms that regulate eosinophil gene transcription and development, roles of eosinophil-fibroblast interactions in fibrogenesis in eosinophil-associated diseases, and mechanisms that regulate eosinophil-mediated tissue remodeling and fibrosis. Recent translational and clinical research includes co-development of the Esophageal String TestÒ (EST) for minimally invasive monitoring of disease status in patients with EoE, and the development of novel peptide nanoparticle biased antagonists targeting CCR3 that block eosinophil recruitment into tissues. Dr. Ackerman is currently a Professor of Biochemistry and Molecular Genetics, University of Illinois at Chicago.
Dagmar Simon is a German and Swiss board certified dermatologist and allergist. In 2010, she became an associate professor. She is the head of the dermatology outpatient and dermato-allergy departments at the Inselspital Bern. Her research interests are in the fields of atopic dermatitis, eczema and eosinophilic diseases with special focus on investigating the pathomechanisms and clinical patterns.
Hans-Uwe Simon is currently a Professor of Pharmacology at the Faculty of Medicine of the University of Bern, Switzerland. His research interest focuses at the molecular mechanisms which drive the pathogenesis of inflammatory diseases and cancer. He was Dean of the Faculty of Medicine of the University of Bern (2016-2020). Since 2021, he serves as President of the Brandenburg Medical School (MHB) in Germany.
Dr. Gerald J. Gleich was born in Escanaba, Michigan and received his degree in Medicine from the University of Michigan. He obtained Internal Medicine residency training at Philadelphia General Hospital and Jackson Memorial Hospital and was a flight surgeon in the United States Air Force. He received postdoctoral training at the University of Rochester and then established a research laboratory for allergic diseases at the Mayo Clinic and Foundation. At Mayo, he was Professor of Medicine and Immunology, Chair of the Department of Immunology, Distinguished Investigator of the Mayo Foundation, and the George M. Eisenberg Professor of Medicine and Immunology. Presently, he is Professor of Dermatology and Medicine at the University of Utah. Dr. Gleich has had a life-long professional commitment to understanding the eosinophil with a focus on its distinctive granules. He and his colleagues have isolated, characterized, identified the cDNAs and the genes and established assays for measurement and localization of all of the principal granule proteins. These efforts lead to the recognition that eosinophil degranulation with release of cytotoxic and cytostimulatory cationic proteins into tissues is characteristic of eosinophil-associated diseases and to recognition of several novel syndromes. 
Dr. Seema Aceves is a Professor of Pediatrics and Medicine at the University of California, San Diego and Rady Children’s Hospital San Diego. Her research lab studies the mechanisms and clinical impacts of tissue remodeling in eosinophilic esophagitis (EoE) and is funded by the NIH and the Campaign Urging Research in Eosinophilic Disease (CURED). She is the Director of the Eosinophilic Gastrointestinal Disorders Clinic at RCHSD and has been the Principal Investigator on multiple clinical and translational research studies on eosinophilic esophagitis (EoE) and non-EoE Eosinophilic Gastrointestinal Disorders (EGIDs). She earned her MD and PhD at UCSD and the Salk Institute as part of the Medical Scientist Training Program. She has authored more than 150 publications on EoE and EGIDs and is the senior author on the clinical guidelines for EoE including the recently published international consensus recommendation for EoE severity. Dr. Aceves is a co-inventor of budesonide oral suspension; the only FDA approved topical therapy for EoE. She is a member of the American Society for Clinical Investigation and the MRD Endowed Chair in Pediatrics at the University of California, San Diego.